NextCure (NXTC) Restructuring Costs (2024 - 2026)
NextCure (NXTC) posted quarterly Restructuring Costs of $414000.0 for Q1 2026, up 35.29% year-over-year from $306000.0 in Q1 2025, and up 26.99% quarter-over-quarter from $326000.0 in Q4 2025.
NextCure (NXTC) Restructuring Costs (2024 - 2026) Analysis & Trends
NextCure's Restructuring Costs history runs 3 years deep, the most recent figure standing at $414000.0 for Q1 2026.
- In Q1 2026, Restructuring Costs rose 35.29% year-over-year to $414000.0; the TTM figure through Mar 2026 stood at $1.4 million (up 15.06% YoY), while the FY2025 annual figure was $1.2 million, down 51.02% from the prior year.
- Restructuring Costs for Q1 2026 stood at $414000.0, up from $326000.0 in the prior quarter.
- The five-year high for Restructuring Costs was $2.5 million in Q1 2024, with the low at $294000.0 in Q3 2025.
- The 3-year median for Restructuring Costs is $346500.0 (2024), against an average of $633625.0.
- The sharpest annual moves came in 2025 and 2026: Restructuring Costs slumped 87.96% in 2025, then soared 35.29% in 2026.
- NextCure's Restructuring Costs stood at $367000.0 in 2024, then declined by 11.17% to $326000.0 in 2025, then advanced by 26.99% to $414000.0 in 2026.
- Business Quant data shows NXTC's Restructuring Costs at $414000.0 in Q1 2026, $326000.0 in Q4 2025, and $294000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.08 Mn |
| Mar 31, 2026 | 414,000.00 |
| Dec 31, 2025 | 326,000.00 |
| Sep 30, 2025 | 294,000.00 |
| Jun 30, 2025 | 318,000.00 |
| Mar 31, 2025 | 306,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Jun 30, 2024 | 502,000.00 |
| Mar 31, 2024 | 2.54 Mn |